Amgen invests $650 million on expansion of US manufacturing network
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
New infrastructure makes it possible for healthcare organizations to integrate AI agents seamlessly into critical workflows like benefit verification and prior authorization
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
BIL also holds an option to increase its equity stake by an additional 15%
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Prolia is a prescription medicine used to treat osteoporosis in women
Subscribe To Our Newsletter & Stay Updated